PortalPublikationenPretreatment diffusion-weighted imaging lesion volume predic...

Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.

Standard

Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. / Krützelmann, Anna Christina; Köhrmann, Martin; Sobesky, Jan; Cheng, Bastian; Rosenkranz, Michael; Röther, Joachim; Schellinger, Peter D; Ringleb, Peter; Gerloff, Christian; Fiehler, Jens; Thomalla, Götz.

in: STROKE, Jahrgang 42, Nr. 5, 5, 2011, S. 1251-1254.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Krützelmann, AC, Köhrmann, M, Sobesky, J, Cheng, B, Rosenkranz, M, Röther, J, Schellinger, PD, Ringleb, P, Gerloff, C, Fiehler, J & Thomalla, G 2011, 'Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.', STROKE, Jg. 42, Nr. 5, 5, S. 1251-1254. <http://www.ncbi.nlm.nih.gov/pubmed/21415399?dopt=Citation>

APA

Krützelmann, A. C., Köhrmann, M., Sobesky, J., Cheng, B., Rosenkranz, M., Röther, J., Schellinger, P. D., Ringleb, P., Gerloff, C., Fiehler, J., & Thomalla, G. (2011). Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. STROKE, 42(5), 1251-1254. [5]. http://www.ncbi.nlm.nih.gov/pubmed/21415399?dopt=Citation

Vancouver

Krützelmann AC, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J et al. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. STROKE. 2011;42(5):1251-1254. 5.

Bibtex

@article{fe794498145b41978b50f308819e6c78,
title = "Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.",
abstract = "Stroke magnetic resonance imaging with perfusion and diffusion weighting has shown its potential to select patients likely to benefit from intravenous thrombolysis with tissue-type plasminogen activator (IV-tPA). We aimed to determine the predictors of favorable outcome in magnetic resonance imaging-selected, acute stroke patients treated with IV-tPA.",
keywords = "Humans, Male, Aged, Female, Middle Aged, Severity of Illness Index, Prospective Studies, Treatment Outcome, Regression Analysis, Age Factors, Predictive Value of Tests, Retrospective Studies, Infusions, Intravenous, *Diffusion Magnetic Resonance Imaging, Fibrinolytic Agents/administration & dosage/*therapeutic use, Middle Cerebral Artery/pathology, Stroke/*drug therapy/*pathology, Thrombolytic Therapy/*methods, Tissue Plasminogen Activator/administration & dosage/*therapeutic use, Humans, Male, Aged, Female, Middle Aged, Severity of Illness Index, Prospective Studies, Treatment Outcome, Regression Analysis, Age Factors, Predictive Value of Tests, Retrospective Studies, Infusions, Intravenous, *Diffusion Magnetic Resonance Imaging, Fibrinolytic Agents/administration & dosage/*therapeutic use, Middle Cerebral Artery/pathology, Stroke/*drug therapy/*pathology, Thrombolytic Therapy/*methods, Tissue Plasminogen Activator/administration & dosage/*therapeutic use",
author = "Kr{\"u}tzelmann, {Anna Christina} and Martin K{\"o}hrmann and Jan Sobesky and Bastian Cheng and Michael Rosenkranz and Joachim R{\"o}ther and Schellinger, {Peter D} and Peter Ringleb and Christian Gerloff and Jens Fiehler and G{\"o}tz Thomalla",
year = "2011",
language = "English",
volume = "42",
pages = "1251--1254",
journal = "STROKE",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.

AU - Krützelmann, Anna Christina

AU - Köhrmann, Martin

AU - Sobesky, Jan

AU - Cheng, Bastian

AU - Rosenkranz, Michael

AU - Röther, Joachim

AU - Schellinger, Peter D

AU - Ringleb, Peter

AU - Gerloff, Christian

AU - Fiehler, Jens

AU - Thomalla, Götz

PY - 2011

Y1 - 2011

N2 - Stroke magnetic resonance imaging with perfusion and diffusion weighting has shown its potential to select patients likely to benefit from intravenous thrombolysis with tissue-type plasminogen activator (IV-tPA). We aimed to determine the predictors of favorable outcome in magnetic resonance imaging-selected, acute stroke patients treated with IV-tPA.

AB - Stroke magnetic resonance imaging with perfusion and diffusion weighting has shown its potential to select patients likely to benefit from intravenous thrombolysis with tissue-type plasminogen activator (IV-tPA). We aimed to determine the predictors of favorable outcome in magnetic resonance imaging-selected, acute stroke patients treated with IV-tPA.

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Severity of Illness Index

KW - Prospective Studies

KW - Treatment Outcome

KW - Regression Analysis

KW - Age Factors

KW - Predictive Value of Tests

KW - Retrospective Studies

KW - Infusions, Intravenous

KW - Diffusion Magnetic Resonance Imaging

KW - Fibrinolytic Agents/administration & dosage/therapeutic use

KW - Middle Cerebral Artery/pathology

KW - Stroke/drug therapy/pathology

KW - Thrombolytic Therapy/methods

KW - Tissue Plasminogen Activator/administration & dosage/therapeutic use

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Severity of Illness Index

KW - Prospective Studies

KW - Treatment Outcome

KW - Regression Analysis

KW - Age Factors

KW - Predictive Value of Tests

KW - Retrospective Studies

KW - Infusions, Intravenous

KW - Diffusion Magnetic Resonance Imaging

KW - Fibrinolytic Agents/administration & dosage/therapeutic use

KW - Middle Cerebral Artery/pathology

KW - Stroke/drug therapy/pathology

KW - Thrombolytic Therapy/methods

KW - Tissue Plasminogen Activator/administration & dosage/therapeutic use

M3 - SCORING: Journal article

VL - 42

SP - 1251

EP - 1254

JO - STROKE

JF - STROKE

SN - 0039-2499

IS - 5

M1 - 5

ER -